brand-logo
Subscribe

Zinzino Expands into New Zealand

by

Zinzino announced the launch of operations in New Zealand. The company described the move as the “strategic next step” in its plan to expand its customer base on an international scale, and pointed to its key location in Oceania as an important hub. The launch is expected to stimulate sales growth in New Zealand and in surrounding regions as distributors throughout the organization work together.

Customer service and market support will take place from the company’s headquarters in Gothenburg and will work synergistically with local consultants in New Zealand.

“This is a perfect time for Zinzino to enter a wide, dynamic market with a tech-forward infrastructure and a digitally savvy population that values quality and sustainability,” said Dag Bergheim Pettersen, Zinzino CEO. “Zinzino’s robust and long-term business model and customer-centered approach will be a springboard to success for our New Zealand Partners.”

Zinzino stated that its business strategy includes the ambition to reach one million customers during 2025 and 20 million by 2035. The company is now active in more than 100 markets with plans for continued global expansion.

Herbalife Acquires Assets of Pro2col and Pruvit

by

Herbalife Ltd. announced it has entered into an agreement to acquire 100% of the assets of Pro2col Health LLC and Pruvit Ventures, Inc. It will now also have a 51% controlling ownership interest in Link BioSciences Inc.

Pro2col, a health and wellness digital application company, uses individual biometrics to provide personalized nutrition recommendations and deliver tailored health and longevity protocols, while Link BioSciences uses proprietary technology to process biometrics, biomarkers, lifestyle data and DNA to formulate nutritional supplements for customers.

A beta rollout of the Pro2col technology platform is expected to be available to select Herbalife distributors during the third quarter of this year with a full US release planned for Q4.

“By acquiring and leveraging Pro2col’s personalized digital technology, along with Link BioSciences’ manufacturing capabilities, Herbalife will be providing our expansive network of distributors with unique opportunities to expand their customer base through a personalized health, wellness and nutrition platform,” said Stephan Gratziani, Herbalife President and incoming CEO. “These investments further accelerate our vision to modernize our business and represent a belief in our business model that better positions us to become the world’s premier health and wellness company, community and platform.”

Herbalife’s acquisition of Pruvit’s assets will expand its health and wellness offerings with a new product category. Pruvit will continue to operate independently under its current ownership for up to two years, during which Herbalife can launch ketone products.

The transactions are expected to close in the second quarter of 2025 and will cost approximately $25-$30 million, with additional conditional payments based on future performance. Herbalife’s partnership with soccer legend Cristiano Ronaldo will support the further development of the Pro2col platform.

“For 45 years, Herbalife has been committed to providing science-backed health and wellness products and a successful business opportunity,” Gratziani said. “We’re excited about these acquisitions and partnership with Cristiano Ronaldo, which will propel Herbalife into its next chapter of growth.”

Nature’s Sunshine Reports Record Revenue in Q4 and Full Year 2024

by

Nature’s Sunshine Products, Inc. announced its financial results for the fourth quarter and full year 2024. The company’s fourth-quarter net sales increased 8.5% to $118.2 million, compared to $108.9 million in the same period last year. This growth was even stronger in constant currency, reaching 10%. Adjusted EBITDA for the quarter increased 6% to $10.3 million, while Adjusted EBITDA saw a slight 0.3% increase to $40.5 million.

For the full year, net sales rose 2% to $454.4 million from $445.3 million in 2023. Operating income was $164 million, down from $167 million in 2023.

These totals highlight record revenue for the company, with the fourth quarter reaching the highest revenue in the company’s 52-year history. The company pointed out other key drivers to its success, including a 21% growth in Asia Pacific and a digital sales surge (17%) in North America.

“As we move into 2025, we reiterate our commitment to delivering the highest quality, innovative products to our customers and to empowering our distributor base to drive continued growth and profitability,” said Terrence Moorehead, CEO of Nature’s Sunshine. “Combining that with our cost-savings initiatives and operational efficiencies, which are already making a positive impact, will enable us to continue making strong progress against our strategic initiatives while delivering long-term, sustainable shareholder value in the face of increased macroeconomic uncertainty.”

The company ended the year with cash and cash equivalents of $84.7 million and no outstanding debt. Forecasts for the full year 2025 includes net sales between $445 and $470 million with an adjusted EBITDA between $38 million to $44 million.

Amway 2024 Sales Reach $7.4 Billion

by

Amway 2024 sales reached $7.4 billion. This total is a 3% decline from 2023, which the company attributed to the strength of the US dollar.

Amway emphasized it has positive momentum in key areas, including a 2% growth within its nutrition category, which now represents 64% of its total global sales. The company also made significant operational advancements and leadership transitions to help fuel its long-term growth.

“Our dedication to the success of Amway Business Owners (ABOs) and their customers around the world drives everything we do,” said Michael Nelson, Amway CEO. “This past year was one of strategic investments, emphasis on timely innovations, and an unwavering commitment to our timeless values – all aimed at helping ABOs grow their businesses.”

The company has also been making significant infrastructure investments, renovating its world headquarters and expanding its manufacturing, quality control and research and development processes.

Sunrider Hosts 2025 Women of Influence Awards

by

Sunrider International hosted the 2025 Women of Influence awards luncheon at its headquarters in Torrance, California. The annual event coincided with the celebration of Women’s History Month and honored women for outstanding leadership, dedication and service to the South Bay community.

Sunrider CEO Sunny Beutler welcomed attendees with an address that reflected on her own involvement with the Women of Influence program.

“I’m grateful to be in a position where I can support women as they lead, grow, and make an impact in their businesses and communities,” Beutler said. “It’s an honor for Sunrider to host and sponsor this event, celebrating the remarkable achievements and leadership of these incredible women.”

Young Living Celebrates International Women’s Day

by

Young Living championed women’s independence through fair-pay opportunities on International Women’s Day. At its partner farm Phytoprod in rural Morocco, Young Living provides opportunities for women to receive pay that is equal to their male counterparts, with wages deposited into their own bank accounts. The Phytoprod farm grows myrtle and rosemary and employs more than 1,000 people, 95% of whom are women, to hand-harvest the plants during peak season.

The Phytoprod fram team also supports women by helping them open bank accounts if they do not already have them. This ensures the women have direct access to their own earnings.

“I used to go to other cities to look for work,” said Soumia Khassouani, Phytoprod Nursery Manager. “Today I work close to home, so I was able to save money and take care of my life, my family, and my community too.”

4Life Sleep Study Published in Journal

by

4Life performed a study about the efficacy of its 4Life Transfer Factor SleepRite. The results of the study, entitled “Assessment of a multi-ingredient dietary supplement on sleep quality: A randomized, double-blinded, placebo-controlled crossover clinical study,” was published in the open access journal Sleep Science and Practice.

Anna Andersen, 4Life Senior Manager of the Research & Development Lab, was the lead author in the article that observed how 4Life Transfer Factor SleepRite worked compared to a placebo group over a period of six weeks in thirty adults.

“The importance of effective and safe solutions for poor sleep and insomnia cannot be overstated,” Andersen said. “It’s an honor to participate in these types of studies and publications, both of which underscore 4Life’s commitment to ongoing scientific research.”

The 4Life Transfer Factor SleepRite formula includes bovine colostrum and egg yolk extracts, ashwagandha root extract, lavender oil, pyridoxal-5-phosphate, melatonin, Gamma-Aminobutyric Acid (GABA), and magnesium.

Significant Developments in Avon Products Bankruptcy Proceedings

by

Avon Products Inc. (API) announced significant developments in its bankruptcy proceedings.  A comprehensive settlement and asset sale has been approved and, as of March 5, the company has emerged from Chapter 11 with a clear path forward.

The company originally filed for bankruptcy in August 2024 to seek protection from debt and liabilities after a number of lawsuits alleging Avon’s talc-based products caused asbestos exposure and led to severe health issues for consumers.

In December 2024, the court approved the sale of API’s assets to Natura &Co, parent company of Avon, including a $125 million credit bid by Natura, the assumption of key contracts and a payment of approximately $3.1 million in cure costs. Natura also committed to a $34 million cash payment, funding the remaining $43 million of a debtor-in-possession financial facility, waiving certain secured debt claims and assuming a $5.9 million underfunded pension plan.

These developments are a significant milestone for Avon Products Inc. and usher in resolution to the heightened financial and legal challenges the company has endured.

The Real Brokerage Reports Q4 and FY 2024 Financial Results

by

The Real Brokerage Inc. announced its financial results for the fourth quarter and full year 2024. Revenue for the full year 2024 was $1.26 billion, an increase of 84% from $689.2 million for the full year 2023. Total real estate transactions in 2024 reached $49 billion, a 90% increase from $25.9 billion in 2023, with 120,601 transactions closed. Fourth quarter transactions saw a 115% increase to $14.6 billion, with 35,370 transactions closed. The total number of agents on the platform increased 77% year-over-year to 24,140 in 2024.

Gross profit for the company reached $30 million in Q4 2024 with a net loss of $6.6 million in Q4 2024, compared to a net loss of $12 million in Q4 2023. Adjusted EBITDA in Q4 was $9.1 million, compared to $8.5 million in Q4 2023. Excluding the positive impact from a $6.2 million non-recurring stock-based compensation balance sheet adjustment during Q4 2023, the comparable adjusted EBITDA during that quarter was $2.3 million.

Gross profit for full-year 2024 was $114.7 million, an 82% increase from 2023. Net loss was $26.5 million, a slight improvement from a loss of $27.5 million in 2023.

“Our strong fourth quarter and record full-year results reflect the power of our platform and our disciplined approach to growth,” said Michelle Ressler, Real Chief Financial Officer. “With our recent fee model changes now established, we’re ensuring we can continue investing in cutting-edge technology and agent support, while driving sustainable year-over-year improvements in our operating and financial performance.”

The company’s strategy to integrate fintech solutions into its platform, beginning with Real Wallet checking accounts, gained traction as 2,500 Real agents utilized the offering. The average deposit balance in these checking accounts was approximately $7 million.

“Real delivered record results in 2024, capping it off with another quarter of exceptional growth,” said Tamir Poleg, Real Chairman and Chief Executive Officer. “Our unwavering commitment to innovation and agent success continues to set us apart in the industry. From launching Real Wallet, our proprietary fintech platform, to rolling out AI-powered tools that enhance agent productivity, we’re building the future of real estate.”

Olive Tree People Close Second Year with Tremendous Growth

by

Olive Tree People, a subsidiary of Oliveda International, Inc., announced an almost 1700% growth rate in its second year with sales of $104.5 million. The company stated that its growth rate outpaces that of other powerhouse brands, including celebrity brands like JLo Beauty by Jennifer Lopez, and growing 600% faster than Beautycounter performed in its second year.

“I believe the time is ripe as more and more of the 168.6 million women in the US are realizing the difference between conventional clean beauty and waterless beauty, and fewer and fewer of the 168.6 million women in the US are willing to spend money on up to 95% fillers, without achieving lasting results,” said Thomas Lommel, Olive Tree People Founder and CEO. “I am convinced that we are experiencing a renaissance of the senses in which soulful and meaningful products make the difference and can therefore offer a 365-day satisfaction guarantee. More and more people are listening to their inner voice, their intuition, and their common sense.”

In two years, the company has created what it calls a “waterless movement” in the US, welcoming more than 50,000 waterless beauty consultants, with expansion into Canada and Europe. Lommel forecasts that more than 125,000 consultants will join the company before the end of 2025.

Natura &Co Considers Potential Sale of Avon

by

Natura &Co announced it is now in “exclusive talks” with asset manager IG4 about Avon‘s potential sale. The company had reported it was considering a sale of its Avon business outside of Latin America in early 2024, which was abruptly paused when its Avon Products unit filed for bankruptcy protection and then resumed in late 2024.

The company’s options have included potential partnerships, spin-offs or sale. By selling or divesting from Avon, Natura &Co hopes to create a strong cash flow from Latin America that would unlock more dividends.

Avon’s US business is not owned by Natura &Co and would not be impacted by the negotiations and sale.

Plexus Receives US Patent for Immune +

by

Plexus Worldwide announced it has received a patent from the US Patent Office for its product Immune +. The plant-based supplement was designed by the company’s in-house Research and Development team to support the body’s defense system.

“We secured this patent by proving our unique ingredient combination activates cytokines to influence immune response,” said Dr. Michael Hartman, PhD, Plexus Worldwide Vice President of Research and Development. “Human cell studies showed the superfood blend in Immune + enhances immune response by encouraging normal immune cell activity.”

The utility patent protects the product’s highly-researched formula, which features black rice extract, prebiotic mushrooms, ascorbic acid and antioxidant blend.